18746787. NANOMATERIALS COMPRISING DISULFIDES simplified abstract (Beam Therapeutics Inc.)

From WikiPatents
Revision as of 05:35, 18 October 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

NANOMATERIALS COMPRISING DISULFIDES

Organization Name

Beam Therapeutics Inc.

Inventor(s)

Cory Dane Sago of Boston MA (US)

Gregory Lawrence Hamilton of Atlanta GA (US)

NANOMATERIALS COMPRISING DISULFIDES - A simplified explanation of the abstract

This abstract first appeared for US patent application 18746787 titled 'NANOMATERIALS COMPRISING DISULFIDES

The present disclosure discusses compositions, preparations, nanoparticles (such as lipid nanoparticles), and/or nanomaterials and methods of their use.

  • Simplified Explanation: This patent application describes various compositions, preparations, nanoparticles, and nanomaterials, along with methods for their utilization.
  • Key Features and Innovation:

- Development of novel compositions and preparations - Utilization of nanoparticles, including lipid nanoparticles - Methods for the application of nanomaterials

  • Potential Applications:

- Drug delivery systems - Biomedical research - Nanotechnology advancements

  • Problems Solved:

- Enhancing drug delivery efficiency - Improving biomedical research techniques - Advancing nanomaterial applications

  • Benefits:

- Increased effectiveness of drug delivery - Enhanced capabilities in biomedical research - Expanded possibilities in nanotechnology

  • Commercial Applications:

- Pharmaceutical industry for drug delivery systems - Biotechnology companies for research purposes - Nanotechnology sector for innovative applications

  • Questions about Nanoparticles:

1. How do lipid nanoparticles differ from other types of nanoparticles? - Lipid nanoparticles have a lipid-based core, which can encapsulate hydrophobic drugs efficiently.

2. What are the potential challenges in utilizing nanoparticles for drug delivery? - Challenges may include stability issues and potential toxicity concerns that need to be addressed in the development process.


Original Abstract Submitted

The present disclosure describes compositions, preparations, nanoparticles (such as lipid nanoparticles), and/or nanomaterials and methods of their use.